Genomic DNA Extraction from Blood: Protocols and Quality Assessment
Genomic DNA extraction from whole blood is a foundational technique in molecular biology that isolates high-molecular-weight DNA from nucleated blood cells for downstream applications such as PCR, sequencing, and genotyping. This method is essential when working with human or animal blood samples for genetic studies, population genetics, or clinical research, and is typically performed using either salting-out precipitation or commercial column-based purification kits. The choice between these approaches depends on factors including required DNA purity, yield, throughput, and whether the DNA will be used for short-read or long-read sequencing applications.
At a Glance
| Aspect | Details |
|---|---|
| Purpose | Isolate high-quality genomic DNA from whole blood for molecular analysis |
| Sample type | Whole blood collected in EDTA, citrate, or heparin anticoagulants |
| Core methods | Salting-out precipitation; silica membrane column purification; magnetic bead-based purification |
| Typical yield | 20-50 µg DNA per 1 mL whole blood (varies by method and white blood cell count) |
| Purity requirements | A260/A280 ratio 1.8-2.0; A260/A230 ratio >2.0 |
| Processing time | 30 minutes to 3 hours depending on method |
| Downstream applications | PCR, qPCR, whole-genome sequencing, genotyping arrays, long-read sequencing |
| Safety level | BSL-1 for blood from healthy donors; BSL-2 for blood from individuals with known infections |
Scientific Principle
Genomic DNA extraction from blood relies on three sequential processes: cell lysis to release DNA, removal of proteins and other cellular components, and DNA precipitation or binding to a solid phase for purification. Whole blood contains erythrocytes (red blood cells), leukocytes (white blood cells), and platelets, but only leukocytes contain nuclei with genomic DNA. Erythrocytes in mammals are anucleate and must be removed or lysed selectively to avoid hemoglobin contamination, which can inhibit downstream enzymatic reactions.
The salting-out method exploits the differential solubility of DNA versus proteins in high-salt solutions. After cell lysis with SDS and proteinase K, proteins are precipitated by adding saturated sodium chloride or ammonium acetate, leaving DNA in solution. The DNA is then recovered by ethanol or isopropanol precipitation. This method produces high-molecular-weight DNA suitable for long-read sequencing applications such as Oxford Nanopore Technology, as demonstrated in the de novo genome assembly of the green shore crab Carcinus maenas [2].
Column-based methods use silica membranes that bind DNA in the presence of chaotropic salts. After lysis and protein digestion, the lysate is passed through a silica column where DNA adsorbs to the membrane. Washing steps remove contaminants, and DNA is eluted in low-salt buffer or water. These methods are faster and more standardized but may shear high-molecular-weight DNA during centrifugation steps.
Magnetic bead-based purification, such as the guanidine isothiocyanate-magnetic bead method, offers an alternative that combines high yield with reduced processing time. This approach has been shown to yield 318.34 ± 4.77 ng/µL from chicken blood samples with A260/A280 ratios between 1.8 and 2.0, while reducing processing time by 40% compared to commercial kits and avoiding toxic reagents like phenol or chloroform [4].
Materials and Instrumentation
Blood Collection and Storage
Blood should be collected in tubes containing anticoagulants. EDTA (purple-top tubes) is preferred for DNA extraction because it chelates calcium and prevents coagulation without interfering with downstream enzymatic reactions. Citrate (blue-top tubes) is acceptable but may require protocol adjustments. Heparin (green-top tubes) should be avoided when possible because heparin inhibits PCR and other enzymatic reactions, and its removal during extraction is inconsistent.
Blood samples can be stored at 4°C for up to 7 days before extraction. For longer storage, freeze aliquots at -80°C, but note that freeze-thaw cycles can degrade DNA and reduce yield. Dried blood spots on filter paper are an alternative storage method that preserves DNA for extended periods at room temperature.
Reagent Systems
Salting-out method reagents:
- Red blood cell lysis buffer (e.g., 0.32 M sucrose, 10 mM Tris-HCl pH 7.5, 5 mM MgCl₂, 1% Triton X-100)
- Nuclear lysis buffer (e.g., 10 mM Tris-HCl pH 8.0, 400 mM NaCl, 2 mM EDTA)
- SDS solution (10% or 20%)
- Proteinase K (20 mg/mL)
- Saturated NaCl solution (approximately 6 M)
- Cold 100% ethanol or isopropanol
- 70% ethanol for washing
- TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) or nuclease-free water for resuspension
Column-based kit components:
- Commercial DNA extraction kit (e.g., Qiagen DNeasy Blood & Tissue Kit, Promega Wizard Genomic DNA Purification Kit)
- Proteinase K
- Binding buffer containing chaotropic salts
- Wash buffers (typically ethanol-containing)
- Elution buffer or nuclease-free water
Magnetic bead method reagents:
- Guanidine isothiocyanate lysis buffer
- Magnetic beads with surface functionalization for DNA binding
- Binding and wash buffers
- Elution buffer
Instrumentation
- Microcentrifuge capable of 13,000-16,000 × g
- Vortex mixer
- Heating block or water bath (56°C for proteinase K digestion)
- Spectrophotometer (e.g., NanoDrop) for DNA quantification and purity assessment
- Agarose gel electrophoresis equipment for DNA integrity checking
- Optional: Automated liquid handler for high-throughput processing
Controls and Quality Standards
Positive and Negative Controls
Include a positive control sample with known DNA yield and quality to verify that the extraction procedure is working correctly. This can be a previously extracted DNA sample stored at -20°C or a commercial human genomic DNA standard.
Include a negative control (extraction blank) containing all reagents but no blood sample. This control detects contamination of reagents with exogenous DNA. If the negative control shows detectable DNA by spectrophotometry or gel electrophoresis, the reagents or workspace may be contaminated.
Internal Quality Metrics
The primary quality metrics for genomic DNA are:
- A260/A280 ratio: 1.8-2.0 indicates pure DNA. Lower ratios suggest protein or phenol contamination; higher ratios may indicate RNA contamination.
- A260/A230 ratio: >2.0 indicates pure DNA. Lower ratios suggest contamination with chaotropic salts, carbohydrates, or organic compounds.
- DNA integrity: High-molecular-weight DNA should appear as a single band above 10 kb on agarose gel without significant smearing.
- Yield: Expected range depends on white blood cell count. Normal human blood yields approximately 20-50 µg DNA per mL whole blood.
Conceptual Workflow
Step 1: Sample Preparation and Red Blood Cell Lysis
Begin with 200-1000 µL of whole blood in a microcentrifuge tube. If using frozen blood, thaw on ice and mix gently by inversion. Add 3 volumes of red blood cell lysis buffer and incubate at room temperature for 5-10 minutes with occasional inversion. Centrifuge at 1,500-2,000 × g for 5 minutes to pellet white blood cells. Carefully remove the supernatant containing lysed red blood cells and hemoglobin. If the pellet appears red, repeat the lysis step.
The selective lysis of red blood cells is critical because hemoglobin and other erythrocyte proteins can inhibit downstream enzymatic reactions. Incomplete removal results in a brownish pellet and may lead to poor DNA purity.
Step 2: Nuclear Lysis and Protein Digestion
Resuspend the white blood cell pellet in nuclear lysis buffer. Add SDS to a final concentration of 0.5-1% and proteinase K to a final concentration of 0.2-0.5 mg/mL. Incubate at 56°C for 30-60 minutes with occasional mixing. Complete digestion is indicated by a clear, viscous solution without visible clumps.
Proteinase K digestion is essential for removing histone proteins bound to DNA and for inactivating nucleases that would degrade the DNA. Insufficient digestion leads to protein contamination and reduced DNA yield.
Step 3: DNA Purification
For salting-out method: Add saturated NaCl solution to a final concentration of approximately 1.5-2 M. Mix vigorously for 15 seconds. Centrifuge at 13,000-16,000 × g for 10 minutes to pellet precipitated proteins. Transfer the supernatant containing DNA to a clean tube. Add 2 volumes of cold 100% ethanol or 0.7 volumes of isopropanol. Mix gently by inversion until DNA precipitates as a visible white thread. Centrifuge at 13,000-16,000 × g for 10 minutes. Wash the DNA pellet with 70% ethanol, air-dry briefly, and resuspend in TE buffer or nuclease-free water.
For column-based method: Add binding buffer containing chaotropic salts to the lysate according to manufacturer instructions. Transfer the mixture to a silica membrane column placed in a collection tube. Centrifuge at 6,000-10,000 × g for 1 minute. Discard flow-through. Add wash buffer, centrifuge, and repeat. Transfer column to a clean microcentrifuge tube. Add elution buffer or water to the membrane, incubate for 1-5 minutes, and centrifuge to elute DNA.
For magnetic bead method: Add magnetic beads and binding buffer to the lysate. Incubate to allow DNA binding to beads. Place tube on magnetic stand to separate beads. Remove supernatant. Wash beads with wash buffer while on magnetic stand. Remove wash buffer. Add elution buffer, incubate, and place on magnetic stand. Transfer eluted DNA to a clean tube.
Step 4: DNA Quantification and Quality Assessment
Measure DNA concentration using spectrophotometry at 260 nm. Assess purity using A260/A280 and A260/A230 ratios. Check DNA integrity by running 100-200 ng of DNA on a 0.8-1% agarose gel alongside a DNA size marker. High-quality genomic DNA appears as a single, sharp band above 10 kb with minimal smearing.
Quality Checks and Result Interpretation
Spectrophotometric Analysis
A NanoDrop or similar microvolume spectrophotometer requires only 1-2 µL of sample. The A260 reading directly correlates with DNA concentration (1 absorbance unit = 50 ng/µL for double-stranded DNA). The A260/A280 ratio indicates protein contamination: values below 1.8 suggest protein carryover, while values above 2.0 may indicate RNA contamination. The A260/A230 ratio indicates contamination with chaotropic salts, phenol, or carbohydrates: values below 2.0 suggest these contaminants are present.
Gel Electrophoresis
Run 100-200 ng of DNA on a 0.8% agarose gel at 5-10 V/cm for 30-60 minutes. Stain with ethidium bromide, SYBR Safe, or similar DNA stain. High-quality genomic DNA appears as a single band near the top of the gel, above the 10 kb marker. Smearing below this band indicates DNA degradation. A bright band at approximately 1.5-2 kb may indicate RNA contamination. A smear throughout the lane suggests shearing during extraction.
Fluorometric Quantification
For applications requiring precise DNA quantification, such as library preparation for next-generation sequencing, use fluorometric methods (e.g., Qubit assay) that specifically detect double-stranded DNA. Spectrophotometry overestimates DNA concentration in the presence of RNA or single-stranded DNA, which can lead to inaccurate input amounts for downstream applications.
Troubleshooting
| Observation | Likely Cause | Discriminating Check |
|---|---|---|
| Low DNA yield | Incomplete cell lysis | Check pellet after RBC lysis; repeat lysis if pellet is red |
| Low DNA yield | Insufficient proteinase K digestion | Verify incubation temperature and time; add fresh proteinase K |
| Low DNA yield | DNA lost during precipitation | Ensure ethanol is cold; check centrifugation speed and time |
| Low A260/A280 ratio (<1.8) | Protein contamination | Repeat proteinase K digestion; increase NaCl concentration in salting-out |
| Low A260/A280 ratio (<1.8) | Phenol contamination (if using phenol-chloroform) | Avoid phenol-chloroform methods; use salting-out or column-based methods |
| High A260/A280 ratio (>2.0) | RNA contamination | Add RNase A (20 µg/mL) after proteinase K digestion; incubate at 37°C for 30 minutes |
| Low A260/A230 ratio (<2.0) | Chaotropic salt carryover (column method) | Increase wash buffer volume or number of washes |
| Low A260/A230 ratio (<2.0) | EDTA contamination | Use TE buffer with lower EDTA concentration; precipitate and wash DNA |
| DNA degradation (smear on gel) | Nuclease contamination | Use fresh, nuclease-free reagents; add EDTA to inhibit nucleases |
| DNA degradation (smear on gel) | Freeze-thaw damage | Use fresh blood; aliquot samples before freezing |
| No DNA detected | Anticoagulant interference | Avoid heparin; use EDTA tubes |
| No DNA detected | Column clogging | Reduce sample volume; increase centrifugation time |
| White precipitate in DNA solution | Salt carryover | Wash DNA pellet more thoroughly with 70% ethanol |
Limitations
Method-Specific Limitations
Salting-out methods produce high-molecular-weight DNA ideal for long-read sequencing but require careful handling to avoid shearing during pipetting and vortexing. The method is more labor-intensive than column-based approaches and may show batch-to-batch variability in yield.
Column-based methods are faster and more reproducible but can shear DNA during centrifugation through the membrane. This makes them less suitable for long-read sequencing applications where high-molecular-weight DNA is critical. Some commercial kits also have limited binding capacity, requiring multiple columns for large sample volumes.
Magnetic bead methods offer a good balance of yield and processing time but require optimization of bead-to-sample ratios and binding conditions for different blood types. The method may be more expensive per sample than salting-out approaches.
Sample-Specific Limitations
Blood from individuals with low white blood cell counts (e.g., chemotherapy patients, immunocompromised individuals) yields less DNA. In such cases, increase the starting blood volume or use a method with higher recovery efficiency.
Hemolyzed blood samples can be problematic because free hemoglobin interferes with spectrophotometric quantification and may inhibit downstream reactions. If only hemolyzed samples are available, increase the number of red blood cell lysis washes.
Blood collected in heparin tubes should be avoided for PCR-based applications. If heparin-containing samples must be used, include a heparin removal step or use a DNA extraction method that effectively removes heparin.
Downstream Application Limitations
For whole-genome sequencing, particularly long-read sequencing, DNA fragment size is critical. The de novo genome assembly of Carcinus maenas required high-molecular-weight DNA for successful Oxford Nanopore sequencing [2]. Similarly, studies using host-enriched DNA from fecal samples for whole-genome sequencing found that blood-derived DNA required a minimum average depth of 20× for reliable genotyping, compared to 50× for fecal DNA [1].
For PCR-based applications, DNA purity is more important than fragment size. Contaminants such as hemoglobin, heparin, or ethanol can inhibit Taq polymerase and other DNA polymerases, leading to failed amplification.
Documentation and Record Keeping
Maintain a laboratory notebook or electronic record for each DNA extraction, including:
- Sample identifier and source
- Date of collection and extraction
- Blood volume and anticoagulant type
- Extraction method and kit lot number
- Any deviations from standard protocol
- Spectrophotometric readings (A260, A280, A230)
- Gel electrophoresis image
- Final DNA concentration and volume
- Storage location and conditions
For clinical or regulated research settings, maintain chain of custody documentation and ensure all reagents are within expiration dates. Document any equipment calibration or maintenance that could affect results.
Biosafety Considerations
Blood samples should be handled as potentially infectious materials. According to the Biosafety in Microbiological and Biomedical Laboratories (BMBL) 6th Edition, blood from healthy human donors can be handled at BSL-1 with standard precautions, including gloves, lab coat, and eye protection [6]. Blood from individuals with known bloodborne pathogens (e.g., hepatitis B, HIV) requires BSL-2 containment.
All work should be performed in a designated laboratory area with restricted access. Use a biosafety cabinet for steps that may generate aerosols, such as vortexing or pipetting. Decontaminate work surfaces with 10% bleach or appropriate disinfectant before and after procedures.
Dispose of blood-contaminated materials (pipette tips, tubes, gloves) in biohazard waste containers. Liquid waste containing blood should be treated with bleach (final concentration 10%) for at least 30 minutes before disposal.
For research involving recombinant or synthetic nucleic acid molecules, follow the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules [7]. This may require Institutional Biosafety Committee (IBC) approval for certain experiments, particularly those involving the introduction of extracted DNA into cells or organisms.
Frequently Asked Questions
Q: Can I use heparin tubes for blood collection if EDTA tubes are not available? A: Heparin is a strong inhibitor of PCR and other enzymatic reactions. While some DNA extraction methods can partially remove heparin, residual inhibition is common. If heparin tubes must be used, include a heparin removal step (e.g., heparinase treatment) or use a DNA extraction method validated for heparin removal. For reliable results, EDTA tubes are strongly preferred.
Q: How long can I store extracted DNA before use? A: Genomic DNA in TE buffer (pH 8.0) is stable at 4°C for several months and at -20°C for years. Avoid repeated freeze-thaw cycles by aliquoting DNA into single-use portions. DNA stored in nuclease-free water is more susceptible to degradation and should be used within weeks or stored at -80°C.
Q: Why does my DNA have a low A260/A230 ratio even though the A260/A280 ratio is acceptable? A: A low A260/A230 ratio (below 2.0) typically indicates contamination with chaotropic salts (from column-based methods), carbohydrates, or organic compounds. This is common when wash buffers are not completely removed during the column purification process. Increase the number of wash steps or ensure complete removal of wash buffer before elution. For salting-out methods, ensure complete removal of ethanol during the washing step.
Q: Can I use the same extraction protocol for animal blood as for human blood? A: The basic principles are the same, but species-specific differences in red blood cell characteristics may require protocol adjustments. For example, nucleated red blood cells in birds, reptiles, and fish require different lysis conditions than mammalian blood. The DNA yield from animal blood also varies with white blood cell count, which differs by species and individual health status.
References and Further Reading
Yang J, Zhang L, Cui L, et al. Assessment of High Throughput Sequencing Quality of Host DNA Enriched From Faeces: A Case From Captive Tiger. 2026. PubMed ID: 41793203. https://pubmed.ncbi.nlm.nih.gov/41793203/
Brons JK, Hackl T, Iacovelli R, et al. De novo whole genome assembly of the globally invasive green shore crab Carcinus maenas via long-read Oxford Nanopore MinION sequencing. 2026. PubMed ID: 41123560. https://pubmed.ncbi.nlm.nih.gov/41123560/
Lerminiaux N, Fakharuddin K, Adam HJ, et al. Rapid identification of microbial pathogens and antimicrobial resistance from bloodstream infections using long-read sequencing. 2026. PubMed ID: 42274466. https://pubmed.ncbi.nlm.nih.gov/42274466/
Xu X, Fang J, Mao L, et al. Improved DNA Extraction for Dairy and Blood Products: A Comparative Evaluation of Yield, Purity, and PCR Compatibility. 2026. PubMed ID: 42195993. https://pubmed.ncbi.nlm.nih.gov/42195993/
Gentile C, Herlihy SE, Shapiro E, et al. Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue). 2026. PubMed ID: 42252866. https://pubmed.ncbi.nlm.nih.gov/42252866/
CDC and NIH. Biosafety in Microbiological and Biomedical Laboratories (BMBL), 6th Edition. U.S. Department of Health and Human Services, 2020. https://www.cdc.gov/labs/bmbl/index.html
National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules/
National Center for Biotechnology Information. NCBI Bookshelf: Molecular Biology and Laboratory Methods. https://www.ncbi.nlm.nih.gov/books/
Related Articles
- DNA Extraction from Yeast: Protocols for Genomic and Plasmid DNA
- DNA Extraction from FFPE Tissues: Protocols and Quality Considerations
- DNA Extraction from Soil: Protocols for Environmental Samples
- DNA Extraction from Blood Spots: Dried Blood Spot Protocol
- RNA Extraction from Blood: Protocols for Total RNA from Whole Blood
- DNA Extraction from Fungi: Protocols for Yeast and Mold